Methods of producing proteins having triple-helix structure

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9018354
APP PUB NO 20120172577A1
SERIAL NO

11909873

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

An objective of the present invention is to provide methods of producing human collagen molecules that are easy to isolate and purify and that have a structure substantially equivalent to that of a natural collagen molecule, wherein host cells that are transduced with a collagen gene synthesize large amounts of human collagen protein derived from a gene introduced into a high exogenous gene expression vector. Another objective of the present invention is to provide collagen molecules produced by the production methods.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
FUSO PHARMACEUTICAL INDUSTRIES LTD7-10 DOSHO-MACHI 1-CHOME CHUO-KU OSAKA-SHI OSAKA 541-0045

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kase, Tetsuo Osaka, JP 1 1
Keshi, Hiroyuki Osaka, JP 18 54
Kimura, Akio Osaka, JP 87 981
Kisaki, Hiroshi Osaka, JP 1 1
Nishihara, Mizuki Osaka, JP 2 16
Ueyama, Hiroshi Osaka, JP 9 37

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 28, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00